Similarly, other tau transgenic mouse lines have shown a reduced number of spine synapses in the absence of NFTs formation [77], and the accumulation of early-stage aggregated tau species is associated with the development of functional deficits during the tauopathy progression [79]. The gene discussed is MAPT; the disease is tauopathy.